SunHo Received U.S. FDA IND Approval to Initiate Phase I Clinical Trial of IAE0972 as Innovative Immunocytokines.
Release time：2021-12-10 09:05:44
SunHo received the IND approval from FDA to initiate phase I clinical trials of IAE0972. IAE0972 is the first EGFR-IL10 immunocytokine with IND approval by both FDA and NMPA.